Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

计划入组 6 人 · 首次发布于 2016 年 10 月 6 日

A Phase 2 Study of CRD-4730 in CPVT

计划入组 12 人 · 首次发布于 2024 年 10 月 26 日

Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

计划入组 7 人 · 首次发布于 2023 年 8 月 22 日

CPV-104

CVT-3833

CD123-CPT

PharmEvo Pvt Ltd.

Pakistan

Cholayil Pvt Ltd.

India

Incozen Therapeutics Pvt Ltd.

India

Solid Biosciences Receives FDA and Health Canada Approval for First-in-Class Gene Therapy Targeting Fatal Heart Rhythm Disorder

FDA-Approved Cancer Drug Ruxolitinib Shows Promise for Treating Cardiac Arrhythmias

Cardurion Pharmaceuticals Recognized as a Top Biotech for Cardiovascular Therapeutics